Related Experiment Videos
Effect of Haemophilus influenzae infection and moxalactam on platelet function in children
Insights
Haemophilus influenzae type b meningitis can affect platelet function. Treatment with moxalactam may also impact platelet function in children, warranting further investigation into bleeding risks.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Pharmacology
Background:
- Haemophilus influenzae type b (Hib) meningitis is a serious infection in children.
- Platelet dysfunction can be a complication of severe infections.
- Understanding treatment effects on hemostasis is crucial for patient care.
Purpose of the Study:
- To investigate the effects of moxalactam, ampicillin, and chloramphenicol on platelet function in children with Hib meningitis.
- To assess the incidence of prolonged bleeding times and abnormal platelet aggregation during and after antibiotic therapy.
Main Methods:
- Prospective randomized study involving 41 children diagnosed with Hib meningitis.
- Assessment of bleeding times and platelet aggregation at hospital admission and end of therapy.
- Comparison of outcomes between children treated with moxalactam versus ampicillin/chloramphenicol.
Main Results:
- At admission, 6 out of 41 children had prolonged bleeding times, and 7 of 9 tested showed abnormal platelet aggregation.
- At the end of therapy, 23% (5 of 22) of children treated with moxalactam exhibited prolonged bleeding times.
- No children in the ampicillin-chloramphenicol group had prolonged bleeding times post-therapy.
Conclusions:
- Both Hib meningitis and moxalactam treatment may independently influence platelet function in children.
- Moxalactam use was associated with a higher incidence of prolonged bleeding times compared to ampicillin/chloramphenicol.
- Further research is needed to elucidate the mechanisms and clinical significance of these findings.
Abstract:
In a prospective randomized study, children with Haemophilus influenzae type b meningitis received moxalactam or ampicillin or chloramphenicol. Of 41 children, 6 had prolonged bleeding times (greater than 6 min), and 7 of 9 tested had abnormal platelet aggregation at hospital admission. At the end of therapy, no children in the ampicillin-chloramphenicol group, compared with 5 of 22 moxalactam-treated children (23%) (P = 0.08), had prolonged bleeding times (6.5 to 7.5 min). Our data suggest that H. influenzae meningitis and treatment with moxalactam may each have an effect on platelet function in children.